NCT04807842View on ClinicalTrials.gov

Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 11, 2021

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions
Bacterial Vaginoses
Interventions
DEVICE

vaginal gel

The placebo gel is a non-buffered gel. The active device is an acidic gel.

Trial Locations (1)

Unknown

RECRUITING

Praxis Dr. Peters, Hamburg

Sponsors

Lead Sponsor

BioClin BV

Collaborators (1)

Avania
All Listed Sponsors
collaborator

Avania

INDUSTRY

lead

BioClin BV

INDUSTRY

NCT04807842 - Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis | Biotech Hunter | Biotech Hunter